Adhesion of Staphylococcus aureus to Surface-Bound Platelets: Role of Fibrinogen/Fibrin and Platelet Integrins

Journal of Infectious Diseases

Volumn 167, Issue 2, 1993, Pages 312-322

  Herrmann, Mathias ^a   Lai, Quintin J ^a   Albrecht, Ralph M ^a   Mosher, Deane F ^a   Proctor, Richard A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOGEN; MONOCLONAL ANTIBODY; THROMBOSPONDIN;

ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BACTERIUM ADHERENCE; CATHETER INFECTION; HOSPITAL INFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

BACTERIAL ADHESION; BLOOD PLATELETS; BLOOD PROTEINS; FIBRIN; FIBRINOGEN; HUMAN; INTEGRINS; LIGANDS; METHYLMETHACRYLATES; MICROSCOPY, ELECTRON, SCANNING; STAPHYLOCOCCUS AUREUS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027531317     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/167.2.312     Document Type: Article

References (50)

1. Maki DG. Infections associated with intravascular lines. In: Remington JS, Swartz MN. eds. Curr Clin Top Infect Dis 1982;3:309-63.
2. Vaudaux PE, Yasuda H, Velazco MI. et al. Role of host and bacterial factors in modulating staphylococcal adhesion to implanted polymer surfaces. J Biomater Appl 1990;5: 134-53.
3. Engbers GHM, Dost L, Hennink WE, Aarts PAMM, Sixma JJ, Feijen J. An in vitro study of the adhesion of blood platelets onto vascular catheters. J Biomed Mater Res 1987;21:613-27.
4. Stillman RM, Soliman F, Garcia L, Sawyer PN. Etiology ofcatheter-associated sepsis. Arch Surg 1977; 112: 1497-9.
5. Scheid WM, Sande MA. Endocarditis and intravascular infections. In: Mandell GL, Douglas RG Jr. Bennett JE, eds. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990:670-706.
6. Angrist AA, Oka M. Pathogenesis of bacterial endocarditis. JAMA 1963; 183:249-52.
7. Sullam PM, Drake TA, Sande MA. Pathogenesis of endocarditis. Am J Med 1985;78(suppl 6B): 110-5.
8. Kuypers JM, Proctor RA. Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun 1989;57:2306-12.
9. Clawson CC, White JG, Herzberg MC. Platelet interaction with bacteria. VI. Contrasting the role of fibrinogen and fibronectin. Am J Hematol 1980;9:43-53.
10. Kessler CM, Nussbaum E, Tuazon CJ. Disseminatedintravascularcoagulation associated with Staphylococcus aureus septicemia is mediated by peptidoglycan-induced platelet aggregation. J Infect Dis 1991;164:101-7.
11. Sullam PM, Valone JA, Mills J. Mechanisms of platelet aggregation by viridans group streptococci. Infect Immun 1987;55: 1743-50.
12. Sullam PM, Payan DG, Dazin PF, Valone JA. Binding of viridans group streptococci to human platelets: A quantitative analysis. Infect Immun 1990;58:3802-6.
13. Yeaman MR, Sullam PM, Dazin PF, Norman DC, Bayer AS. Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis. J Infect Dis 1992;166:65-73.
14. Packham MA. The behavior of platelets at foreign surfaces. Proc Soc Exp Bioi Med 1988;189:261-74.
15. Scheid WM, Valone JA, Sande MA. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest 1978;61: 1394-404.
16. Chugh TO, Burns GJ, Shuhaiber HJ, Bahr GM. Adherence ofStaphylococcus epidermidis to fibrin-platelet clots in vitro mediated by lipoteichoic acid. Infect Immun 1990;58:315-9.
17. Cheung AL, Fischetti VA. The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis 1990; 161: 1177-86.
18. Murphy-Ullrich JE, Mosher OF. Interactions of thrombospondin with endothelial cells: Receptor-mediated binding and degradation. J Cell Bioi 1987;105:1603-11.
19. Yatohgo T, Izumi M, Kashiwagi H. Hayashi M. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct 1988; 13:281-92.
20. Montgomery RR, Kunicki TJ, Taves C, Pidard O, Corcoran M. Diagnosis of Bernard-Soulier syndrome and Glanzrnann's thrombasthenia with a monoclonal assay on whole blood. J Clin Invest 1983;71:385-9.
21. Pidard O, Montgomery RR, Bennett JS, Kunicki TJ. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein Ilb-Illa complex with intact platelets. J Bioi Chern 1983;258: 12582-6.
22. Coller BS. A new murine monoclonal antibody reports an activationdependent change in the conformation and/or microenvironment of the platelet glycoprotein Ilb/Illa complex. J Clin Invest 1985; 76: 101-8.
23. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GP Ib as a platelet receptor for von Willebrand factor. Blood 1983;61:99-110.
24. Coller BS, Beer JH. Scudder LE, Steinberg MH. Collagen-platelet interactions: Evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPlIb/I1Ia mediated by adhesive proteins. Blood 1989;74: 182-92.
25. Cheresh DA, Spiro RC. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Bioi Chern 1987;262: 17703-11.
26. Asch AS, Barnwell J, Silverstein RL, Nachman RL. Isolation of the thrombospondin membrane receptor. J Clin Invest 1987;79: 1054-61.
27. Yamamoto N, Greco NJ, Barnard MR, et al. Glycoprotein Ib (GPIb)dependent and GPIb-independent pathways of thrombin-induced platelet activation. Blood 1991;77: 1740-8.
28. Kettner C, Shaw E. D-Phe-pro-arg-CH2Cl, a selective affinity label for thrombin. Thromb Res 1979;14:969-73.
29. Moss DE, Fahrney D. Kinetic analysis ofdifferences in brain acetylcholinesterase from fish or mammalian sources. Biochem Pharmacal 1978;27:2693-8.
30. Vaudaux PE, Waldvogel FA, Morgenthaler JJ, Nydegger DE. Adsorption of fibronectin onto polymethylmethacrylate and promotion of Staphylococcus aureus adherence. Infect Immun 1984;45:768-74.
31. Albrecht RM, Simmons SR, Mosher OF. Colloidal gold-fibrinogen: A marker for fibrinogen receptors. In: Matsuda M, Iwanaga S, Takada A, Henschen A, eds. Fibrinogen 4. Current basic and clinical aspects. New York: Elsevier, 1990;87-92.
32. Herrmann M, Vaudaux PE, Pittet O, et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988; 158:693-701.
33. Herrmann M, Jaconi MEE, Dahlgren C, Stendahl O, Waldvogel FA, Lew PD. Neutrophil bactericidal activity on biological surfaces against Staphylococcus aureus. Surface bound extracellular matrix proteins activate intracellular killing by oxygen dependent and independent mechanisms. J Clin Invest 1990;86:942-51.
34. Vaudaux PE, Suzuki R, Waldvogel FA, Nydegger UE. Foreign body infection: Role offibronectin as a ligand for the adherence ofStaph ylococcus aureus. J Infect Dis 1984; 150:546-53.
35. Herrmann M, Suchard SJ, Boxer LA, Waldvogel FA, Lew PD. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun 1991;59:279-88.
36. Jacobson BS, Branton D. Plasma membrane: Rapid isolation and exposure of the cytoplasmic surface by use of positively charged beads. Science 1977; 195:302-4.
37. Cohn EJ, Strong LE, Hughes WL Jr, et al. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chern Soc 1946;68:459-75.
38. Albrecht RM, Goodman SL, Simmons SR. Distribution and movement of membrane-associated platelet glycoproteins: Use of colloidal gold with correlative video-enhanced light microscopy, low-voltage highresolution scanning electron microscopy, and high-voltage transmission electron microscopy. Am J Anat 1989; 185: 149-64.
39. Feldman DS Jr, Gagnon J. StatView. Berkeley, CA: Abacus Concepts, 1991.
40. Kerins OM, Murray R, FitzGerald GA. Prostacyclin and prostaglandin E I: Molecular mechanisms and therapeutic utility. Prog Hemost Thromb 1991;10:307-37.
41. Loftus JC, Choate J, Albrecht RM. Platelet activation and cytoskeletal reorganization: High voltage electron microscopic examination ofintact and triton-extracted whole mounts. J Cell Bioi 1984;98:2019-25.
42. Ware JA, Kang J, OeCenzo MT, et al. Platelet activation by a synthetic hydrophobic polymer, polymethylmethacrylate. Blood 1991;78: 1713-21.
43. Vroman L, Adams AL, Klings M, Fischer GC, Munoz PC, Solensky RP. Reactions of formed elements of blood with plasma proteins at interfaces. Ann NY Acad Sci 1977;283:65-76.
44. Cheung AL, Krishnan M, Jaffe EA, Fischetti VA. Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest 1991;87:2236-45.
45. Ginsberg MH, Loftus J, Plow EF. Platelets and the adhesion receptor superfamily. Prog Clin Bioi Res 1988;283: 171-95.
46. Aiken ML, Ginsberg MH, Plow EF. Identification of a new class of inducible receptors on platelets. Thrombospondin interacts with platelets via a GPIIb-IIIa mechanism. J Clin Invest 1986;78: 1713-6.
47. Siess W, Lapetina EG. Prostacyclin inhibits platelet aggregation induced by phorbol ester of'Ca?" ionophore at steps distal to activation of protein kinase C and Ca2+-dependent protein kinases. Biochem J 1989;258:57-65.
48. Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood 1989;74: 1181-95.
49. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein lIb-IlIa complex. Blood 1988;71:831-43.
50. Choay J. Structure and activity of heparin and its fragments: An overview. Semin Thromb Hemostasis 1989; 15:359-64.